Previous studies have shown that histone acetylation can increase the efficiency of several anticancer drugs targeting the DNA [8-11]; studies also shown that HDAC activity inhibitors enhance in vitro sensitivity of tumor cells to radiation [12-14]. Here, HDAC9 is linked to neoplasm.